Cocrystal Pharma Will Ride A Wave Of Clinical Trial Success

Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, hepatitis C viruses, coronaviruses and noroviruses. They have a proprietary structural biology, enzymology and medicinal chemistry expertise enables Cocrystal Pharma to develop novel antiviral agents. These technologies and our market-focused approach to drug discovery are designed to effectively create small molecule therapeutics that are safe, effective and convenient to administer.